Grant S - Search Results

1

MEK1/2 inhibitors potentiate UCN-01 lethality in human multiple myeloma cells through a Bim-dependent mechanism.

Pei XY, Dai Y, Tenorio S, Lu J, Harada H, Dent P, Grant S. Pei XY, et al. Among authors: grant s. Blood. 2007 Sep 15;110(6):2092-101. doi: 10.1182/blood-2007-04-083204. Epub 2007 May 31. Blood. 2007. PMID: 17540843 Free PMC article.

2

Bryostatin 1 modulates the proliferation and lineage commitment of human myeloid progenitor cells exposed to recombinant interleukin-3 and recombinant granulocyte-macrophage colony-stimulating factor.

Li F, Grant S, Pettit GR, McCrady CW. Li F, et al. Among authors: grant s. Blood. 1992 Nov 15;80(10):2495-502. Blood. 1992. PMID: 1421372 Free article.

3

c-kit expression by CD34+ bone marrow progenitors and inhibition of response to recombinant human interleukin-3 following exposure to c-kit antisense oligonucleotides.

Catlett JP, Leftwich JA, Westin EH, Grant S, Huff TF. Catlett JP, et al. Among authors: grant s. Blood. 1991 Dec 15;78(12):3186-91. Blood. 1991. PMID: 1720696 Free article.

4

The macrocyclic lactone protein kinase C activator, bryostatin 1, either alone, or in conjunction with recombinant murine granulocyte-macrophage colony-stimulating factor, protects Balb/c and C3H/HeN mice from the lethal in vivo effects of ionizing radiation.

Grant S, Traylor R, Pettit GR, Lin PS. Grant S, et al. Blood. 1994 Feb 1;83(3):663-7. Blood. 1994. PMID: 8298128 Free article.

5

Role of c-jun in human myeloid leukemia cell apoptosis induced by pharmacological inhibitors of protein kinase C.

Freemerman AJ, Turner AJ, Birrer MJ, Szabo E, Valerie K, Grant S. Freemerman AJ, et al. Among authors: grant s. Mol Pharmacol. 1996 May;49(5):788-95. Mol Pharmacol. 1996. PMID: 8622627

6

Positive and negative regulation of JNK1 by protein kinase C and p42(MAP kinase) in adult rat hepatocytes.

Jarvis WD, Auer KL, Spector M, Kunos G, Grant S, Hylemon P, Mikkelsen R, Dent P. Jarvis WD, et al. Among authors: grant s. FEBS Lett. 1997 Jul 21;412(1):9-14. doi: 10.1016/s0014-5793(97)00705-9. FEBS Lett. 1997. PMID: 9257680 Free article.

7

Agents that down-regulate or inhibit protein kinase C circumvent resistance to 1-beta-D-arabinofuranosylcytosine-induced apoptosis in human leukemia cells that overexpress Bcl-2.

Wang S, Vrana JA, Bartimole TM, Freemerman AJ, Jarvis WD, Kramer LB, Krystal G, Dent P, Grant S. Wang S, et al. Among authors: grant s. Mol Pharmacol. 1997 Dec;52(6):1000-9. doi: 10.1124/mol.52.6.1000. Mol Pharmacol. 1997. PMID: 9396780

8

Coordinate regulation of stress- and mitogen-activated protein kinases in the apoptotic actions of ceramide and sphingosine.

Jarvis WD, Fornari FA Jr, Auer KL, Freemerman AJ, Szabo E, Birrer MJ, Johnson CR, Barbour SE, Dent P, Grant S. Jarvis WD, et al. Among authors: grant s. Mol Pharmacol. 1997 Dec;52(6):935-47. doi: 10.1124/mol.52.6.935. Mol Pharmacol. 1997. PMID: 9415703

9

Effect of bryostatin 1 on taxol-induced apoptosis and cytotoxicity in human leukemia cells (U937).

Wang S, Guo CY, Castillo A, Dent P, Grant S. Wang S, et al. Among authors: grant s. Biochem Pharmacol. 1998 Sep 1;56(5):635-44. doi: 10.1016/s0006-2952(98)00188-9. Biochem Pharmacol. 1998. PMID: 9783732

10

Evidence for involvement of mitogen-activated protein kinase, rather than stress-activated protein kinase, in potentiation of 1-beta-D-arabinofuranosylcytosine-induced apoptosis by interruption of protein kinase C signaling.

Jarvis WD, Fornari FA Jr, Tombes RM, Erukulla RK, Bittman R, Schwartz GK, Dent P, Grant S. Jarvis WD, et al. Among authors: grant s. Mol Pharmacol. 1998 Nov;54(5):844-56. doi: 10.1124/mol.54.5.844. Mol Pharmacol. 1998. PMID: 9804619

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,844 results

Search Page

Filters